Nurix
Mike Lizarzaburu has a solid background in the pharmaceutical industry, with extensive experience in medicinal chemistry. Mike started their career at Amgen in 2001 as a Sr Scientist and worked there for thirteen years. In 2015, they moved to ChemPartner SF as a Principal Scientist, where they stayed for seven years. In 2021, Mike joined ChemPartner US as the Director of Medicinal Chemistry and held this role for two years. Currently, they work at Nurix Therapeutics as the Associate Director of Medicinal Chemistry, a position they have held since 2023.
Mike Lizarzaburu attended the University of California, Davis, but no specific information is available regarding the degree or field of study.
This person is not in any teams
Nurix
3 followers
Nurix Therapeutics discovers drugs that harness the body's natural process to control protein levels. Nurix is focused on developing drugs to treat cancer including the novel, small molecule immuno-oncology agents.